Skip to content
Shuttingdown

BIOLIFE SOLUTIONS INC

Electromedical & Electrotherapeutic Apparatus · BOTHELL · WA

No longer listed

High confidence (85%)

Updated Oct 18, 2026, 12:07 AM

What is happening

Derived by rule set status-rules-2026.09.7

The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

Latest material event: BIOLIFE SOLUTIONS INC deregistered its securities (Oct 16, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. BIOLIFE SOLUTIONS INC deregistered its securities

    Oct 16, 2026

    Registration withdrawn

    • SEC EDGAR — “15-12G 1 d76862d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-36362 BioLife Solutions, Inc. (BioLife Solutions, LLC, as successor by merger to BioLife Solutions, Inc.) (Exact name of registrant as specified in its charter) c/o Repligen Corporation 41 Seyon Street, Bldg. 1, Suite 100 Waltham,…”

  2. BIOLIFE SOLUTIONS INC was delisted from its exchange

    Oct 6, 2026

    Delisting effective

    • SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0000834365 BIOLIFE SOLUTIONS INC 001-36362 3303 Monte Villa Parkway Suite 310 Bothell WA WASHINGTON 98021 425-686-6002 Common Stock 17 CFR 240.12d2-2(a)(3) Katelin Rowe CDO Analyst 2026-10-06”

  3. BIOLIFE SOLUTIONS INC received a delisting notice from its exchange

    Oct 6, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The disclosure under the Explanatory Note of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. As a result of the Mergers, BioLife has ceased to exist as a separate legal entity and therefore no longer fulfills the listing requirements of The Nasdaq Capital Market ( Nasdaq ). In connection with the consummation of the Mergers, on October 5, 2026, BioLife notified Nasdaq that it anticipates that the Mergers will close prior to the opening of trading on O…”

Company information

Founded
—
Employees (estimate)
—
Industry
Electromedical & Electrotherapeutic Apparatus
Subindustry
—
Listing
SEC lists the ticker BLFS on Nasdaq.
SEC CIK
0000834365
Website
—
LinkedIn
—
Headquarters
BOTHELL, WA
Also known as
CRYOMEDICAL SCIENCES INC
Legal entities
BIOLIFE SOLUTIONS INC

Sources

Every material source used to build this profile.

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    15-12G 1 d76862d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-36362 BioLife Solutions, Inc. (BioLife Solutions, LLC, as successor by merger to BioLife Solutions, Inc.) (Exact name of registrant as specified in its charter) c/o Repligen Corporation 41 Seyon Street, Bldg. 1, Suite 100 Waltham,…
    View source record

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    BIOLIFE SOLUTIONS INC — Electromedical & Electrotherapeutic Apparatus (SIC 3845) — BOTHELL, WA
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    X0203 0001354457 Nasdaq Stock Market LLC 0000834365 BIOLIFE SOLUTIONS INC 001-36362 3303 Monte Villa Parkway Suite 310 Bothell WA WASHINGTON 98021 425-686-6002 Common Stock 17 CFR 240.12d2-2(a)(3) Katelin Rowe CDO Analyst 2026-10-06
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The disclosure under the Explanatory Note of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. As a result of the Mergers, BioLife has ceased to exist as a separate legal entity and therefore no longer fulfills the listing requirements of The Nasdaq Capital Market ( Nasdaq ). In connection with the consummation of the Mergers, on October 5, 2026, BioLife notified Nasdaq that it anticipates that the Mergers will close prior to the opening of trading on O…
    View source record

Status history

Every derived status, with the rule that produced it.

  • NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Oct 18, 2026, 12:07 AM

    The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

  • DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Oct 11, 2026, 12:08 AM

    The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.

  • UNKNOWN → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Oct 11, 2026, 12:08 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.